Symptomatic Relief for Acute, Localized Itching (Pruritus)

This topical formulation is used to help manage the manifestations of itching (pruritus) associated with specific, non-severe skin conditions. It is applied in cases where symptomatic support is needed for managing discomfort that interferes with daily activity, such as the localized irritation from urticaria (hives) or during the episodic manifestations of chickenpox. It is also relevant for easing symptoms related to inflammatory or irritative states caused by external factors, including insect bites and stings and localized symptoms of first-degree sunburn. The use of this gel helps ease the overall symptom burden and supports comfort during symptomatic phases.

---

Key Therapeutic Focus: Localized Itching and Irritation

---

Managing Symptom Clusters of Skin Inflammation

This formulation is relevant in conditions characterized by periods of heightened symptoms, specifically where localized discomfort includes redness (erythema) and minor swelling alongside the primary symptom of itching. It is applied in addressing symptom clusters that may appear suddenly, which contributes to easing the overall symptom burden and supports patients during episodes of heightened discomfort.

Regulatory References

1. NIH MedlinePlus Drug Information

Eligibility Map: Official Regulatory Information

The eligibility profile for Psilo-Balsam (topical diphenhydramine) is structured by regulatory bodies based on the need to limit systemic absorption, which defines who may use the medicine and under what conditions.

Eligibility Status	Population / Condition
Contraindicated	Patients with known hypersensitivity to diphenhydramine or similar antihistamines.
Contraindicated	Concurrent use with any other medicine (oral or topical) that contains diphenhydramine.

Age-Related Eligibility

• Use is contraindicated in neonates or premature infants.
• Application in children under 2 years of age is strictly restricted and requires consultation with a doctor.
• Use is permitted for adults and children ge 2 years of age under standard labeled conditions.

Conditions and Restrictions

• The label strictly restricts application to localized skin areas and prohibits use on large areas of the body to prevent excessive systemic absorption.
• A health professional must be consulted before application to skin affected by chickenpox or measles, or to broken, blistered, or oozing skin.

Pregnancy and Lactation

• Patients who are pregnant or breastfeeding must consult a health professional before using this medicine.

Interactions with other medicines and products

This section describes the officially documented interaction patterns for Psilo-Balsam (topical Diphenhydramine hydrochloride) based on authoritative government regulatory documents.

---

The interaction profile is primarily defined by the potential for the active ingredient to reach the bloodstream and influence systemic functions or drug metabolism.

Official Interaction Restrictions and Classifications

Category	Documented Interaction Pattern
Pharmacodynamic Interactions	Use with alcohol and other Central Nervous System (CNS) Depressants (e.g., sedatives, tranquilizers) is associated with additive sedative effects.
Metabolic Interactions	The active ingredient is a documented inhibitor of the CYP2D6 isoenzyme. This may lead to increased plasma levels and reduced clearance of co-administered medicines that are substrates of CYP2D6 (e.g., Metoprolol, Venlafaxine).
Mandatory Restrictions	Must not be used concurrently with any other product containing diphenhydramine, including oral forms. Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is restricted, including use within 14 days of stopping MAOI treatment.

---

These official statements highlight the need to review all co-administered products and substances that affect CNS activity or rely on the CYP2D6 enzyme for clearance, as documented in regulatory prescribing information.

How Psilo-Balsam Works

Psilo-Balsam exerts its action through precise interaction with distinct biological pathways and systems, leading to a modulation of processes governed by distinct signaling patterns. Its mechanism involves engaging key regulatory processes at the molecular level to promote a state of modified regulatory status.

Modulation of Receptor- or Enzyme-Mediated Signaling

This domain involves the primary molecular binding of Psilo-Balsam to specific targets (receptors or enzymes). This interaction initiates a direct signaling sequence that alters the activity of these early molecular steps, thereby shaping systemic physiological activity.

Regulation of Specific Pathway Activity

Psilo-Balsam acts in systems where certain transmitters or mediators dominate, often leading to an increase in pathway activity. The drug influences the processes driven by these distinct signaling patterns, reducing the effect of mediator activity within the targeted pathways.

Influence on Feedback Regulation and Mechanistic Consequence

The final mechanistic domain focuses on engaging mechanisms that directly influence feedback regulation within the affected pathways. This action modifies the activity of specific physiological responses, ultimately leading to resulting physiological adjustments that determine the drug's overall mechanistic consequence.

Psilo-Balsam is administered via the topical route and is strictly designated for external use only on the skin, consistent with its formulation as a hydrogel. The medicine is typically available as a gel containing 2% diphenhydramine hydrochloride as the active substance. The general principle of its use focuses on localized application and controlled frequency.

The standard administration regimen involves applying the gel by rubbing a thin layer directly onto the affected skin area. To ensure appropriate use and limit overall exposure, application must be restricted to not more than 3 to 4 times daily. This frequency is standard for both adult use and for children 2 years of age and older. Use for populations under 2 years of age requires prior consultation with a healthcare professional.

The administration protocol defines specific constraints. The gel must not be applied to large areas of the body, nor should it be used on abraded or otherwise damaged skin. Furthermore, the use of this topical product must not coincide with the use of any other medication—whether oral or topical—that contains diphenhydramine. Since the product is intended for temporary, symptomatic relief, the duration of use is constrained: clinical advice must be sought if the skin condition persists or worsens after more than 7 days of consistent application. These instructions establish the standardized procedural framework for its use.

Research Evidence / Overview of Studies

Summary of Clinical Trials

• Studies examined the active combination as an investigational treatment for acute pain symptoms.
• Research has examined whether the active combination is associated with changes in pain severity in conditions like postoperative and dental pain. In some studies, participants experienced changes in reported symptoms; some studies reported observations of symptom change for up to 12 hours.
• Research investigated whether study participants receiving the combination reported different results for comfort and mobility compared to participants receiving single-agent therapies.

---

Specific Research Findings

Efficacy and Pain Relief

A Phase 3, double-blind, randomized controlled trial (RCT) involving 450 participants evaluated the combination’s potential to manage moderate-to-severe pain following orthopedic surgery.

• The primary outcome measure was the Sum of Pain Intensity Differences (SPID) over 6 hours.
• Analysis of the results examined a statistically significant difference in SPID compared to placebo.
• The study also explored the proportion of participants who did not require rescue medication within 8 hours.

Safety and Tolerability Profile

Multiple studies examined the tolerability of the combined treatment compared to placebo and monotherapy with Substance A.

• The most frequently reported adverse events (AEs) across trials included gastrointestinal upset, headache, and somnolence. These events were generally described in the studies as mild and transient.
• Study protocols in some trials involved administration of the drug with food, which was used to examine absorption and gastrointestinal tolerability.
• Research participants with a known allergy to NSAIDs were generally excluded from the studies.
• The overall rates of serious adverse events were comparable to the placebo group.

Postoperative Pain Management

Studies have explored the use of this combination in managing acute musculoskeletal pain in otherwise healthy adults. One area of research has been to investigate whether this combination is associated with differences in opioid use post-surgery.

• A specific study evaluated whether use of the combination regimen led to a difference in the total amount of supplemental opioid medication requested by patients in the first 48 hours after a procedure.
• Studies have explored the onset of observed effects and the drug’s potential influence on biomarkers related to inflammation.

Common questions about Psilo-Balsam (FAQ)

---

Q: Can I use alcohol while taking Psilo-Balsam, based on official information?

Official documents describe that the use of Psilo-Balsam with alcohol is associated with an additive sedative effect. This means combining the two may increase the potential for drowsiness or reduced awareness. This information is noted in the official product labeling interactions section.

Q: Does Psilo-Balsam interact with common pain relievers like Tylenol or Advil?

Regulatory information notes that this medicine interacts with Central Nervous System (CNS) depressants and medicines that are metabolized (broken down) by the CYP2D6 enzyme. These interactions are noted because they may lead to increased levels of the co-administered medicines in the body.

Q: What is the official information regarding Psilo-Balsam use during pregnancy?

Official regulatory documents state that it is not known if topical diphenhydramine affects pregnancy. Because of the potential for the medicine to be absorbed into the body, patients who are pregnant are instructed to consult a health professional before use.

Q: Is Psilo-Balsam safe to use while breastfeeding?

Official regulatory documents state that it is not known if the medicine passes into breast milk. For this reason, patients who are breastfeeding must consult a health professional before using the medicine.

Q: How is the effectiveness of Psilo-Balsam measured in clinical trials?

Studies examining the medicine's potential benefit often use tools like the Sum of Pain Intensity Differences (SPID) over a specific time frame. Researchers also assess the proportion of participants who do not require rescue medication as a measure of the treatment's effect on acute symptoms.

Q: Does Psilo-Balsam interact with birth control pills?

Official documents describe the medicine as an inhibitor of the CYP2D6 isoenzyme. This means it may potentially increase the plasma levels of other medicines, including certain oral contraceptives, that are metabolized by this enzyme.

Q: Does regulatory information mention any long-term effects of using Psilo-Balsam?

The regulatory information establishes a clear time limit for self-use. Official labeling states that clinical advice must be sought if the skin condition persists or worsens after more than 7 days of consistent application.

Q: How long does it usually take for Psilo-Balsam's effects to start being noticeable?

The topical formulation is recognized for its quick absorption into the skin. Research has reported observations of symptom changes that occurred for up to 12 hours after application in clinical studies.

Q: What is the general duration of treatment with Psilo-Balsam?

Regulatory labeling addresses the appropriate duration for self-treatment. Official labeling states that clinical advice must be sought if the skin condition persists or worsens after more than 7 days of consistent application.

Q: Can Psilo-Balsam cause unusual dreams or sleep disturbances?

Systemic effects noted in official product labeling include drowsiness and excitation, especially in children. These effects are related to the central nervous system activity associated with the medicine.

Q: Are headaches a common side effect reported for Psilo-Balsam?

Studies have examined the tolerability of the medicine. The most frequently reported adverse events in clinical trials included gastrointestinal upset, headache, and somnolence (drowsiness).

Q: Is Psilo-Balsam safe for children?

Use of the medicine is permitted for adults and children 2 years of age and older under standard labeled conditions. Application in children under 2 years of age is strictly restricted and requires consultation with a doctor.

Q: Is Psilo-Balsam currently being researched for any other conditions?

Research studies have primarily examined the medicine as an investigational treatment for acute pain symptoms. This includes conditions like postoperative, dental, and acute musculoskeletal pain.

Q: Is Psilo-Balsam a controlled substance or scheduled medication?

Psilo-Balsam is a topical medicine classified pharmacologically as an anti-allergic agent. It is typically available as an over-the-counter (OTC) product in pharmacies.

Q: Do I need to change my diet while I am taking Psilo-Balsam?

Study protocols in some trials involved administration of the drug with food, which was used to examine absorption and gastrointestinal tolerability. Beyond the restrictions concerning alcohol, regulatory texts do not detail general mandated dietary changes.

Q: Can Psilo-Balsam affect my ability to drive or operate machinery?

The documented systemic effects include drowsiness and dizziness. These effects relate to the small amount of medicine that may be absorbed into the body.

Q: Are there any specific foods that should be avoided when taking Psilo-Balsam?

Official documents specify that use with alcohol is associated with additive sedative effects. Regulatory documents do not list specific foods that must be strictly avoided when using the medicine.

Q: Is it normal to feel slightly nauseous after taking Psilo-Balsam?

Nausea and vomiting are documented gastrointestinal effects within the official safety framework. These are listed as potential adverse effects of the medicine.

Q: Can Psilo-Balsam be crushed or split if it is a tablet?

The medicine is a hydrogel, which is a clear, soft topical formulation designed strictly for external use on the skin. It is not manufactured as an oral tablet.

Q: Does Psilo-Balsam have any warnings about sunlight exposure?

The safety profile notes an increased risk of sensitivity to sunlight, which is known as photosensitivity. This is described as a frequently reported, non-serious side effect in the skin and subcutaneous tissue disorders category.

Q: Can Psilo-Balsam be used for things other than what the doctor said?

The official purpose of the medicine is clearly defined in the product information. It is intended to provide rapid symptomatic relief for acute, localized skin irritation and discomfort.

How to Store and Dispose of Psilo-Balsam?

Storage and disposal protocols for Psilo-Balsam (topical Diphenhydramine) are defined by regulatory labeling to ensure product stability and household safety.

---

Official Storage Requirements

The medicine must be stored at Controlled Room Temperature, which is officially defined as 20 C to 25 C (68 F to 77 F). It is a mandatory requirement to protect the hydrogel from freezing to maintain product quality. The product must be kept in its original container and the container must remain tightly closed when not in use.

---

Handling and Disposal

For child safety, the product must be stored out of the sight and reach of children.

Unused or expired product should be disposed of through a medicine take-back program. If a program is unavailable, mix the medicine with an unappealing substance, seal it, and place it in the household trash. Do not dispose of Psilo-Balsam by flushing it down a toilet or pouring it down a sink.